Advances in biodegradable nano-sized polymer-based ocular drug delivery
C Lynch, PPD Kondiah, YE Choonara, LC du Toit… - Polymers, 2019 - mdpi.com
The effective delivery of drugs to the eye remains a challenge. The eye has a myriad of
defense systems and physiological barriers that leaves ocular drug delivery systems with …
defense systems and physiological barriers that leaves ocular drug delivery systems with …
Biomaterial-mediated factor delivery for spinal cord injury treatment
Spinal cord injury (SCI) is an injurious process that begins with immediate physical damage
to the spinal cord and associated tissues during an acute traumatic event. However, the …
to the spinal cord and associated tissues during an acute traumatic event. However, the …
Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus–current status
Type 2 diabetes mellitus (T2DM) is a major chronic disease that is prevalent worldwide, and
it is characterized by an increase in blood glucose, disturbances in the metabolism, and …
it is characterized by an increase in blood glucose, disturbances in the metabolism, and …
Nanowired drug delivery across the blood-brain barrier in central nervous system injury and repair
A Sharma, P Menon, D F. Muresanu… - CNS & Neurological …, 2016 - benthamdirect.com
The blood-brain barrier (BBB) is a physiological regulator of transport of essential items from
blood to brain for the maintenance of homeostasis of the central nervous system (CNS) …
blood to brain for the maintenance of homeostasis of the central nervous system (CNS) …
Therapeutic nanoparticles in the brain: A review of types, physicochemical properties and challenges
LS de Lima, MR Mortari - International Journal of Pharmaceutics, 2022 - Elsevier
One of the main obstacles in the treatment of neurological diseases, perhaps the biggest
one, is the delivery of therapeutic compounds to the central nervous system, and …
one, is the delivery of therapeutic compounds to the central nervous system, and …
Co-administration of TiO2 nanowired mesenchymal stem cells with cerebrolysin potentiates neprilysin level and reduces brain pathology in Alzheimer's disease
HS Sharma, DF Muresanu, JV Lafuente, R Patnaik… - Molecular …, 2018 - Springer
Abstract Neprilysin (NPL), the rate-limiting enzyme for amyloid beta peptide (AβP), appears
to play a crucial role in the pathogenesis of Alzheimer's disease (AD). Since mesenchymal …
to play a crucial role in the pathogenesis of Alzheimer's disease (AD). Since mesenchymal …
Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles …
A Sharma, DF Muresanu, JV Lafuente, R Patnaik… - Molecular …, 2015 - Springer
Military personnel are often subjected to sleep deprivation (SD) during combat operations.
Since SD is a severe stress and alters neurochemical metabolism in the brain, a possibility …
Since SD is a severe stress and alters neurochemical metabolism in the brain, a possibility …
TiO2-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following …
L Feng, A Sharma, F Niu, Y Huang, JV Lafuente… - Molecular …, 2018 - Springer
Abstract DL-3-n-butylphthalide (DL-NBP) is one of the constituents of Chinese celery extract
that is used to treat stroke, dementia, and ischemic diseases. However, its role in traumatic …
that is used to treat stroke, dementia, and ischemic diseases. However, its role in traumatic …
[HTML][HTML] Bone marrow mesenchymal stem cells encapsulated thermal-responsive hydrogel network bridges combined photo-plasmonic nanoparticulate system for the …
H An, Q Li, J Wen - Journal of Photochemistry and Photobiology B: Biology, 2020 - Elsevier
Spinal cord injury (SCI) is a distressing injury and an irretrievable dramatic event that can
debilitate victims for lifespan. Recovery and treatment of SCI is critical challenges for …
debilitate victims for lifespan. Recovery and treatment of SCI is critical challenges for …
Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease
HS Sharma, DF Muresanu, A Nozari… - Progress in Brain …, 2019 - Elsevier
Alzheimer's disease (AD) is estimated to be afflicting over 55 millions of individual worldwide
in 2018–19 for which no suitable clinical therapeutic measures have been developed so far …
in 2018–19 for which no suitable clinical therapeutic measures have been developed so far …